ACHILLION PHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - November 6, 2009

Attached files

file filename
10-Q - FORM 10-Q - ACHILLION PHARMACEUTICALS INCd10q.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INCdex312.htm
EX-31.1 - CERTIFICATION OF PRESIDENT & CEO PURSUANT TO SECTION 302 - ACHILLION PHARMACEUTICALS INCdex311.htm
EX-10.1 - AMENDMENT NUMBER 3 TO RESEARCH COLLABORATION AND LICENSE AGREEMENT - ACHILLION PHARMACEUTICALS INCdex101.htm
EX-32.1 - CERTIFICATION OF PRESIDENT & CEO PURSUANT TO SECTION 906 - ACHILLION PHARMACEUTICALS INCdex321.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Achillion Pharmaceuticals, Inc. (the “Company”) for the quarter ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Mary Kay Fenton, Chief Financial Officer of the Company, hereby certifies, pursuant to Section 1350 of Chapter 63 of Title 18, United States Code, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 6, 2009  

/s/ Mary Kay Fenton

  Mary Kay Fenton
  Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

ACHILLION PHARMACEUTICALS INC Reports

Also read